Marvin Edeas - Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress
The developments Marvin Edeas (Visiter la page web Justia.com de Marvin edeas) has made have all proved to carry a real use. In the US and Europe, he has filed two patents. Marvin Edeas has successfully distinguished two Nrf-2 modulators isolated from peptides and proteins, which can activate the antioxidant system of defence. Medicine, cosmetology and dietetics could all stand to reap benefits from Oyster hydrolyzate.
Chair of the International Society (ISANH) and the French Society of Antioxidants (SFA) and Founder of the World Mitochondria Society (WMS)
Marvin Edeas is the founder and Chair of the International Society of Antioxidants in Nutrition & Health (ISANH) which was created in the year 1998. Research on inflammation, mitochondria and microbiota, cell signalling, Nrf2 transcription factors activation and their significance in different pathologies are at the heart of his work. The connection between mitochondria and microbiota is his main focus. He, ISANH and the SFA work to transfer their research to real applications whether clinical, pharmaceutical, nutritional or cosmetic. Through the SFA, Marvin Edeas promotes collaboration and trade between researchers, biologists, public health actors and doctors, etc.
Important Research on HIV
Back in 1997, Marvin Edeas identified the factors which lead to blastogenic plasma in HIV Type 1 cases. Sidaction rewarded him for his work with HIV. Marvin Edeas looked into the effects of oxidative stress and co-infections in HIV patients at Paris Descartes University.
Marvin Edeas - a Visiting Professor with the Cochin Institute
Marvin Edeas performs studies which examine how microbiota metabolites effect the mitochondrial activity of nephrology patients. Ever since 2016, he has worked with the Paris Descartes University (Cochin Institute) as a visiting professor. He got to be a member of the team in control of Oxidative Stress, Cell Proliferation and Inflammation. Marvin Edeas regularly works with INSERM, Paris Descartes University and CNRS in the Development, Reproduction, Cancer Department.